A carregar...
Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa
Ocular Adnexal Lymphomas are the first cause of primary ocular malignancies, and among them the most common are MALT Ocular Adnexal Lymphomas. Recently systemic immunotherapy with anti-CD20 monoclonal antibody has been investigated as first-line treatment; however, the optimal management for MALT Oc...
Na minha lista:
| Publicado no: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4575717/ https://ncbi.nlm.nih.gov/pubmed/26425558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/895105 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|